SL Science Holding Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	3.27	3.36	0.88
Revenue Growth	-	282.68%	-
Cost of Revenue	2.01	1.43	0.14
Gross Profit	1.26	1.93	0.74
Selling, General & Admin	1.78	1.11	0.64
Research & Development	1.78	2.02	-
Operating Expenses	3.57	3.13	0.64
Operating Income	-2.31	-1.2	0.1
Interest & Investment Income	0.07	0.05	0
Other Non Operating Income (Expenses)	-0.03	0.02	0.43
Pretax Income	-2.26	-1.13	0.53
Income Tax Expense	0.11	0.06	0.13
Net Income	-2.37	-1.19	0.4
Net Income to Common	-2.37	-1.19	0.4
Net Income Growth	-	-	-
Shares Outstanding (Basic)	4	3	-
Shares Outstanding (Diluted)	4	3	-
Shares Change	-	-	-
EPS (Basic)	-0.64	-0.45	-
EPS (Diluted)	-0.64	-0.45	-
EPS Growth	-	-	-
Free Cash Flow	-3.28	0.27	-2.64
Free Cash Flow Per Share	-0.89	0.10	-
Gross Margin	38.41%	57.46%	83.96%
Operating Margin	-70.65%	-35.56%	11.02%
Profit Margin	-72.46%	-35.42%	45.40%
Free Cash Flow Margin	-100.30%	8.09%	-300.04%
EBITDA	-2.28	-1.15	0.13
EBITDA Margin	-69.87%	-34.27%	14.79%
D&A For EBITDA	0.03	0.04	0.03
EBIT	-2.31	-1.2	0.1
EBIT Margin	-70.65%	-35.56%	11.02%
Effective Tax Rate	-	-	25.12%

SEC Filings: 10-K · 10-Q